Zekri et al. [13] reported that the high serum IL-10 levels in patients with HCC result from the secretion of IL-10 by tumor cells, in addition to the production at the site of inflammatory changes with activated infiltrating mononuclear cells in the liver. This evidence concerns the gene IL10 and neoplasm.